Back to funds

Siren, L.L.C.

hedge fundUpdated 10 days ago

Managed by Siren, L.L.C. • Latest filing Q3 2026

Portfolio value
$4.2B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
99.7%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$3.4B
Q1 2026$3.6B
Q2 2026$4.9B
Q3 2026$4.2B

Top holdings

113 positions as of Q3 2026

View filing
S

Scholar Rock Holding Corporation

Value
$453M
Shares
9.38M
% Port
10.71%
K

Kymera Therapeutics, Inc.

Value
$311.3M
Shares
2.78M
% Port
7.36%
E

Erasca, Inc.

Value
$193.5M
Shares
13.20M
% Port
4.57%
R

Revolution Medicines, Inc.

Value
$174.5M
Shares
850.0K
% Port
4.12%
B

BeOne Medicines AG

Value
$170.2M
Shares
465.0K
% Port
4.02%
T

Tango Therapeutics, Inc.

Value
$169.3M
Shares
6.78M
% Port
4.00%
M

Veradermics, Incorporated

Value
$160.5M
Shares
1.32M
% Port
3.79%
A

Arrowhead Pharmaceuticals, Inc.

Value
$149.9M
Shares
2.29M
% Port
3.54%
E

Edgewise Therapeutics, Inc.

Value
$113.8M
Shares
2.80M
% Port
2.69%
R

Rhythm Pharmaceuticals, Inc.

Value
$103.4M
Shares
1.09M
% Port
2.44%
B

Bicara Therapeutics Inc

Value
$102.4M
Shares
5.50M
% Port
2.42%
P

Parabilis Medicines Inc

Value
$96.6M
Shares
2.99M
% Port
2.28%
L

Lexicon Pharmaceuticals, Inc.

Value
$83.3M
Shares
44.30M
% Port
1.97%
S

Spyre Therapeutics Inc

Value
$77.3M
Shares
868.6K
% Port
1.83%
T

Tyra Biosciences, Inc.

Value
$74.3M
Shares
3.40M
% Port
1.76%
C

Hemab Therapeutics Holdings Inc

Value
$73M
Shares
2.37M
% Port
1.72%
A

Amylyx Pharmaceuticals, Inc.

Value
$72.2M
Shares
2.48M
% Port
1.71%
E

Enliven Therapeutics, Inc.

Value
$67.6M
Shares
1.48M
% Port
1.60%
S

Septerna, Inc.

Value
$66.5M
Shares
1.70M
% Port
1.57%
R

Relay Therapeutics, Inc.

Value
$58.9M
Shares
3.26M
% Port
1.39%

Explore